Publication: Bibw 2992, a Novel Irreversible Egfr/Her2 Tyrosine Kinase Inhibitor, in Chemonaive Patients with Adenocarcinoma of the Lung and Activating Egfr Mutations
| dc.contributor | 腫瘤醫學研究所 | en |
| dc.contributor.author | YANG, CHIH-HSIN | en |
| dc.contributor.author | SHIH, JIN-YUAN | en |
| dc.creator | YANG, CHIH-HSIN;SHIH, JIN-YUAN;SU, WU- CHOU;HSIA, TE-CHUN | en |
| dc.date | 2009 | en |
| dc.date.accessioned | 2010-06-29T06:30:26Z | |
| dc.date.accessioned | 2018-07-09T02:30:37Z | |
| dc.date.available | 2010-06-29T06:30:26Z | |
| dc.date.available | 2018-07-09T02:30:37Z | |
| dc.date.issued | 2009 | |
| dc.identifier.uri | http://ntur.lib.ntu.edu.tw//handle/246246/186849 | |
| dc.language | en-us | en |
| dc.language.iso | en_US | |
| dc.relation | JOURNAL OF THORACIC ONCOLOGY v.4 n.9 SUPPL. 1 pp.S294-S295 | en |
| dc.relation.ispartof | JOURNAL OF THORACIC ONCOLOGY | |
| dc.relation.journalissue | 1 | |
| dc.relation.journalvolume | v.4 | |
| dc.relation.pages | S294-S295 | |
| dc.title | Bibw 2992, a Novel Irreversible Egfr/Her2 Tyrosine Kinase Inhibitor, in Chemonaive Patients with Adenocarcinoma of the Lung and Activating Egfr Mutations | en |
| dspace.entity.type | Publication |